BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

INTRA-CELLULAR THERAPIES, INC. — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

INTRA-CELLULAR THERAPIES, INC.

via INTRA-CELLULAR THERAPIES, INC.

1st Quarter (Jan 1 - Mar 31) · 2023Posted Apr 13, 2023Filing document ↗LDA record ↗

Expenses$40Kself-filed spend

Client

Name: INTRA-CELLULAR THERAPIES, INC.
Description: Biopharmaceutical company
Location: New York · United States of America

Registrant

Firm: INTRA-CELLULAR THERAPIES, INC.
Location: New York, New York, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Inflation Reduction Act (IRA) implementation
LobbyistsANDREW SPERLING
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.